← Back to headlines
Barclays Lowers Price Target on Hims & Hers Health (HIMS)
Barclays has lowered its price target on Hims & Hers Health, Inc. (HIMS) to $25 while keeping an Overweight rating.
5 Mar, 20:28 — 5 Mar, 20:28
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Police Official Implicated as P784-M Counterfeit Cigarettes Seized in Negros Occidental
just now
Manila Water Strengthens Supply Amidst El Niño Threat with Calawis Plant
just now
Philippine President's Aid Distribution in Batangas Sparks Controversy
just now